Osteoporosis is a degenerative, debilitating bone disease that is increasingly prevalent in postmenopausal women. Despite its being classified as one of the four most dangerous health issues today, a ...

A research team from the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine of the University of Hong Kong ...

In a recent article published in PLOS One, researchers determined whether patients with newly diagnosed osteoporosis received delayed pharmacologic treatment due to the coronavirus disease 2019 (COVID ...

Low back pain can be stubbornly mysterious. For millions of people, the ache persists for years, even when doctors can’t find ...

Can an augmented health care delivery pathway reduce the chances of those future fractures and improve outcomes that are important to patients? Two University of Alabama at Birmingham researchers have ...

Osteoporosis treatment was associated with lower mortality and hospitalization rates among people older than 80 who had suffered fractures, according to a study presented at the Endocrine Society’s ...

Patients with glucocorticoid-induced osteoporosis on romosozumab show greater gains in lumbar spine bone mineral density than those on denosumab and comparable gains with those on teriparatide.

—This analysis found significant disparities in healthcare expenditures and health-related quality of life in individuals with and without osteoporosis, increasing the need for effective prevention ...